ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesD36.1

D36.1

Billable

Benign neoplasm of peripheral nerves and autonomic nervous system

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/05/2025

Code Description

ICD-10 D36.1 is a billable code used to indicate a diagnosis of benign neoplasm of peripheral nerves and autonomic nervous system.

Key Diagnostic Point:

Benign neoplasms of the peripheral nerves and autonomic nervous system are non-cancerous growths that can arise from the nerve tissues. These neoplasms may include schwannomas, neurofibromas, and other nerve sheath tumors. They can occur in various locations throughout the body, including the arms, legs, and trunk, and may present with symptoms such as pain, numbness, or weakness depending on their size and location. Diagnosis typically involves imaging studies such as MRI or CT scans, and histological examination may be required to confirm the benign nature of the tumor. While these tumors are generally not life-threatening, they can lead to significant morbidity due to their effects on surrounding tissues and nerves. Management may involve observation, surgical excision, or other interventions based on the symptoms and the tumor's impact on the patient's quality of life.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Variety of benign neoplasm types (e.g., schwannomas, neurofibromas)
  • Potential for overlapping symptoms with malignant conditions
  • Need for precise documentation of tumor location and characteristics
  • Variability in treatment approaches based on tumor size and symptoms

Audit Risk Factors

  • Inadequate documentation of tumor characteristics
  • Failure to specify the location of the neoplasm
  • Misclassification of benign neoplasms as malignant
  • Lack of supporting imaging or histological evidence

Specialty Focus

Medical Specialties

Neurology

Documentation Requirements

Detailed clinical notes including symptoms, imaging results, and treatment plans.

Common Clinical Scenarios

Patients presenting with neuropathic pain or sensory deficits due to peripheral nerve tumors.

Billing Considerations

Ensure accurate coding of the specific type of benign neoplasm and its location.

Oncology

Documentation Requirements

Pathology reports confirming benign nature and treatment history.

Common Clinical Scenarios

Management of patients with previously diagnosed benign nerve tumors undergoing surveillance.

Billing Considerations

Documentation must clearly differentiate benign tumors from malignant ones to avoid coding errors.

Coding Guidelines

Inclusion Criteria

Use D36.1 When
  • According to ICD
  • 10 coding guidelines, D36
  • 1 should be used when a benign neoplasm of the peripheral nerves or autonomic nervous system is confirmed

Exclusion Criteria

Do NOT use D36.1 When
  • Exclusion criteria include malignant neoplasms and conditions that do not involve nerve tissues

Related ICD-10 Codes

Related CPT Codes

64727CPT Code

Excision of peripheral nerve tumor

Clinical Scenario

Used when a benign neoplasm is surgically removed.

Documentation Requirements

Operative report detailing the procedure and findings.

Specialty Considerations

Ensure the procedure is linked to the correct diagnosis code.

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The transition to ICD-10 has allowed for more specific coding of benign neoplasms, improving the accuracy of data collection and reimbursement processes. D36.1 provides a clear distinction from malignant neoplasms, which is crucial for treatment planning and patient management.

ICD-9 vs ICD-10

The transition to ICD-10 has allowed for more specific coding of benign neoplasms, improving the accuracy of data collection and reimbursement processes. D36.1 provides a clear distinction from malignant neoplasms, which is crucial for treatment planning and patient management.

Reimbursement & Billing Impact

reimbursement processes. D36.1 provides a clear distinction from malignant neoplasms, which is crucial for treatment planning and patient management.

Resources

Clinical References

  • •
    ICD-10-CM Official Guidelines for Coding and Reporting

Coding & Billing References

  • •
    ICD-10-CM Official Guidelines for Coding and Reporting

Frequently Asked Questions

What is the difference between benign and malignant neoplasms?

Benign neoplasms are non-cancerous growths that do not invade surrounding tissues or metastasize, while malignant neoplasms are cancerous and can spread to other parts of the body.